Literature DB >> 22076494

Mechanistic links between oxidative/nitrosative stress and tumor necrosis factor alpha in letrozole-induced murine polycystic ovary: biochemical and pathological evidences for beneficial effect of pioglitazone.

M A Rezvanfar1, M A Rezvanfar1, A Ahmadi, H A Shojaei Saadi, M Baeeri, M Abdollahi.   

Abstract

This study aimed to investigate the possible relationship between ovarian functionality and the oxidative response during cystogenesis induced by hyperandrogenization with letrozole and examine protective effect of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist, pioglitazone (PIO), in polycystic ovary (PCO). Ovarian cysts were induced by oral administration of letrozol (1 mg/kg/day) for 21 consecutive days in the female rats. Effective dose of PIO (20 mg/kg/day) was administrated orally for 21 days. Serum estradiol (E), progesterone (P), testosterone (T), and the ovarian immunomodulator prostaglandin E (PGE) were analyzed as biomarkers of ovarian function. To determine the role of oxidative stress in PCO, the level of cellular lipid peroxidation (LPO), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and peroxynitrite (ONOO), and tumor necrosis factor alpha (TNF-α) as a marker of inflammation and apoptosis were measured in serum and the ovaries. Letrozole-induced PCO in rats exhibited a significant increase in LPO and ONOO in serum and ovary while significantly decreased serum and ovarian SOD, CAT, and GPx. Serum T and TNF-α, and ovarian PGE were increased in animals with cysts compared with healthy controls, while E and P diminished. When compared to control group, letrozole-treated group showed irregular sexual cycles, polycystic ovaries characterized by high incidence of sub-capsular ovarian cyst with diminished or scant granulosa cell layer, increased number of atretic pre-antral and antral follicles and absence of corpus luteum. There were almost no primary, secondary, and tertiary follicles observed in PCO rats. All measured parameters were improved by PIO and reached close to normal levels. The present study further supports the role of oxidative/nitrosative stress and infiammatory responses in the pathogenesis of letrozole-induced hyperandrogenic PCO rats. Results indicate that PIO is able to exert direct antioxidative and anti-inflammatory effects on the endocrine, biochemical, and pathological alterations independent of its possible effects mediated via increased insulin sensitivity in hyperandrogenized PCO.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22076494     DOI: 10.1177/0960327111426589

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  17 in total

1.  Bio-enhancement of Soy Isoflavones (Genistein & Daidzein) Using Bacillus coagulans in Letrozole Induced Polycystic Ovarian Syndrome by Regulating Endocrine Hormones in Rats.

Authors:  Jeshica Bulsara; Arun Soni; Pragati Patil; Kripa Halpati; Sonal Desai; Sanjeev Acharya
Journal:  Probiotics Antimicrob Proteins       Date:  2022-04-11       Impact factor: 4.609

2.  Pharmaceutical and Pharmacological Evaluation of the Effect of Nano-Formulated Spironolactone and Progesterone on Inflammation and Hormonal Levels for Managing Hirsutism Experimentally Induced in Rats.

Authors:  Reham I Amer; Ghada E Yassin; Reem A Mohamed; Ahmed M Fayez
Journal:  AAPS PharmSciTech       Date:  2021-07-13       Impact factor: 3.246

3.  Beneficial effects of pioglitazone and metformin in murine model of polycystic ovaries via improvement of chemerin gene up-regulation.

Authors:  Nahid Kabiri; Mohammad Reza Tabandeh; Seyed Reza Fatemi Tabatabaie
Journal:  Daru       Date:  2014-04-24       Impact factor: 3.117

4.  Antioxidant effect of genistein on ovarian tissue morphology, oxidant and antioxidant activity in rats with induced polycystic ovary syndrome.

Authors:  Samira Rajaei; Alireza Alihemmati Ph D; Ali Abedelahi Ph D
Journal:  Int J Reprod Biomed       Date:  2019-03-03

5.  Quercetin and polycystic ovary syndrome, current evidence and future directions: a systematic review.

Authors:  Fatemeh Pourteymour Fard Tabrizi; Fatemeh Hajizadeh-Sharafabad; Maryam Vaezi; Hamed Jafari-Vayghan; Mohammad Alizadeh; Vahid Maleki
Journal:  J Ovarian Res       Date:  2020-01-31       Impact factor: 4.234

6.  Effect of 150 kHz electromagnetic radiation on the development of polycystic ovaries induced by estradiol Valerate in Sprague Dawley rats.

Authors:  Stephanie Mohammed; Venkatesan Sundaram; Nikolay Zyuzikov
Journal:  J Ovarian Res       Date:  2021-02-05       Impact factor: 4.234

7.  Ovarian aging-like phenotype in the hyperandrogenism-induced murine model of polycystic ovary.

Authors:  Mohammad Amin Rezvanfar; Habib A Shojaei Saadi; Maziar Gooshe; Amir Hosein Abdolghaffari; Maryam Baeeri; Mohammad Abdollahi
Journal:  Oxid Med Cell Longev       Date:  2014-02-19       Impact factor: 6.543

8.  Therapeutic potentials of Quercetin in management of polycystic ovarian syndrome using Letrozole induced rat model: a histological and a biochemical study.

Authors:  Sarwat Jahan; Abira Abid; Sidra Khalid; Tayyaba Afsar; Ghazala Shaheen; Ali Almajwal; Suhail Razak
Journal:  J Ovarian Res       Date:  2018-04-03       Impact factor: 4.234

9.  The effects of thylakoid-rich spinach extract and aqueous extract of caraway (Carum carvi L.) in letrozole-induced polycystic ovarian syndrome rats.

Authors:  Saeed Sherafatmanesh; Maryam Ekramzadeh; Nader Tanideh; Mohammad-Taghi Golmakani; Farhad Koohpeyma
Journal:  BMC Complement Med Ther       Date:  2020-08-12

10.  Protective effect of alpha-lipoic acid and omega-3 fatty acids against cyclophosphamide-induced ovarian toxicity in rats.

Authors:  Dhanya Venugopalan Nair; M Usha Rani; A Gopala Reddy; B Kala Kumar; M Anudeep Reddy; M Lakshman; U Rajkumar
Journal:  Vet World       Date:  2020-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.